A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle.
暂无分享,去创建一个
L. Kiesel | E. Nieschlag | M. Simoni | R. Greb | B. Sonntag | J. Gromoll | K. Grieshaber | Manuela Simoni | E. Nieschlag | Barbara Sonntag | Ludwig Kiesel
[1] L. Kiesel,et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation , 2005, Pharmacogenetics and genomics.
[2] F. Morón,et al. Human controlled ovarian hyperstimulation outcome is a polygenic trait. , 2004, Pharmacogenetics.
[3] A. Loft,et al. A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment. , 2003, Human reproduction.
[4] L. Real,et al. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. , 2003, Fertility and sterility.
[5] R. Pierson,et al. A new model for ovarian follicular development during the human menstrual cycle. , 2003, Fertility and sterility.
[6] K. Loveland,et al. Inhibins, activins and follistatin in reproduction. , 2002, Human reproduction update.
[7] C. Welt,et al. Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium , 2002, Experimental biology and medicine.
[8] S. Sudo,et al. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. , 2002, Molecular human reproduction.
[9] E. Nieschlag,et al. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. , 2002, Human reproduction update.
[10] B. Fauser,et al. Antimüllerian hormone serum levels: a putative marker for ovarian aging. , 2002, Fertility and sterility.
[11] B. Dahlbäck,et al. Improved Hemoglobin Status and Reduced Menstrual Blood Loss among Female Carriers of Factor V Leiden – An Evolutionary Advantage? , 2001, Thrombosis and Haemostasis.
[12] A. Zeleznik. Follicle Selection in Primates: “Many Are Called but Few Are Chosen”1 , 2001, Biology of reproduction.
[13] M. Eijkemans,et al. Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development. , 2001, Human reproduction.
[14] S. Ng,et al. Absence of Mutations in the Coding Regions of Follicle-Stimulating Hormone Receptor Gene in Singapore Chinese Women with Premature Ovarian Failure and Polycystic Ovary Syndrome , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[15] C. AbouZahr,et al. Maternal mortality at the end of a decade: signs of progress? , 2001, Bulletin of the World Health Organization.
[16] E. Nieschlag,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Ovarian Response to Follicle-Stimulating Hormone (FSH) Stimulation Depends on the FSH Receptor Genotype* , 2022 .
[17] A. Hsueh,et al. Initial and cyclic recruitment of ovarian follicles. , 2000, Endocrine reviews.
[18] G. Conway,et al. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome , 1999, Clinical endocrinology.
[19] E. Nieschlag,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Mutational Analysis of the Follicle-Stimulating Hormone (FSH) Receptor in Normal and Infertile Men: Identification and Characterization of Two Dis , 2022 .
[20] J. Gromoll,et al. Identification of allelic variants in the follicle-stimulating hormone receptor genes of females with or without hypergonadotropic amenorrhea. , 1998, Fertility and sterility.
[21] B. Fauser,et al. Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years. , 1998, Human reproduction.
[22] W. Hop,et al. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development. , 1998, The Journal of clinical endocrinology and metabolism.
[23] E. Nieschlag,et al. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. , 1997, Endocrine reviews.
[24] Yao-Tseng Chen,et al. Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. , 1996, The American journal of pathology.
[25] W. Hop,et al. Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. , 1995, Fertility and sterility.
[26] W. Hop,et al. Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. , 1990, Fertility and sterility.
[27] D. Baird. A model for follicular selection and ovulation: lessons from superovulation. , 1987, Journal of steroid biochemistry.
[28] G. Hodgen. The dominant ovarian follicle , 1982 .
[29] James B. Brown,et al. Pituitary Control of Ovarian Function — Concepts Derived from Gonadotrophin Therapy , 1978, The Australian & New Zealand journal of obstetrics & gynaecology.
[30] Jacquelyn A. Mattfield. Many Are Called, But Few Are Chosen. , 1972 .